novel
coronaviru
diseas
also
known
world
health
organ
rapidli
evolv
pandem
believ
viru
evolv
unknown
speci
bat
wuhan
wet
anim
market
southern
china
estim
case
fatal
rate
wide
rang
mortal
rate
report
like
reflect
variabl
background
implement
public
health
intervent
outbreak
expect
infect
larg
portion
world
popul
case
fatal
rate
repres
signific
mortal
healthcar
burden
longterm
pulmonari
complic
individu
recov
moder
sever
infect
remain
unclear
matter
great
interest
wide
spectrum
symptomatolog
diseas
manifest
rang
complet
asymptomat
carrier
critic
respiratori
failur
multiorgan
dysfunct
death
sever
present
often
fatal
outcom
consist
associ
sever
comorbid
includ
cardiovascular
diseas
advanc
age
like
immunolog
explan
given
current
understand
weaken
immun
system
diabet
individu
advanc
age
clear
whether
dialysisdepend
patient
endstag
renal
diseas
esrd
greater
risk
sever
diseas
manifest
poorer
outcom
present
case
unit
state
longterm
dialysisdepend
esrd
patient
report
thu
far
pandem
patient
male
esrd
secondari
biopsyproven
iga
nephropathi
hemodialysi
sinc
late
known
coronari
arteri
diseas
ischem
cardiomyopathi
underw
percutan
coronari
intervent
left
anterior
descend
right
coronari
arteri
shortli
initi
dialysi
improv
cardiac
eject
fraction
optim
medic
therapi
initi
losartan
mg
daili
diagnos
ischem
cardiomyopathi
increas
maximum
toler
dose
mg
daili
month
prior
admiss
work
profession
remain
activ
compliant
prescrib
medic
treatment
point
activ
list
renal
transplant
patient
recent
travel
south
korea
earli
januari
return
unit
state
late
januari
surg
epidem
daegu
south
korea
identifi
remain
good
health
without
notabl
symptom
earli
march
five
day
prior
admiss
present
local
urgent
care
evalu
nausea
vomit
abdomin
cramp
subject
fever
notabl
respiratori
complaint
diagnos
viral
gastroenter
given
recommend
symptom
manag
discharg
home
even
present
emerg
depart
similar
complaint
note
lowgrad
temperatur
laboratori
test
includ
electrolyt
liver
function
test
lactic
acid
blood
count
unremark
chest
xray
time
show
signific
focal
consolid
mild
patchi
increas
interstiti
mark
bilater
lung
base
note
describ
possibl
atelectasi
nausea
improv
emerg
depart
symptom
attribut
viral
gastroenter
bad
sushi
report
eat
day
prior
follow
discharg
emerg
depart
went
home
note
feel
better
except
develop
loos
stool
two
day
later
attend
routin
outpati
hemodialysi
treatment
report
feel
better
sinc
discharg
emerg
depart
continu
intermitt
loos
stool
approxim
time
per
day
report
cough
respiratori
symptom
time
end
dialysi
note
febril
blood
cultur
sent
show
bacteri
growth
seen
cardiolog
clinic
later
morn
dialysi
treatment
elect
appoint
note
cough
wait
room
given
strict
precaut
given
intent
travel
essenti
reason
follow
day
patient
travel
commerci
airlin
southern
california
utah
present
emerg
depart
continu
intermitt
vomit
fever
report
mild
congest
cough
new
chest
xray
time
utah
note
mild
interstiti
promin
vagu
infiltr
right
lung
base
influenza
test
report
neg
prescrib
azithromycin
given
chest
xray
find
next
day
attend
schedul
hemodialysi
transient
visitor
commun
dialysi
facil
utah
report
fever
malais
eager
return
california
given
acut
sick
return
southern
california
even
earlier
plan
use
commerci
airlin
feel
quit
ill
continu
fever
gastrointestin
symptom
furthermor
respiratori
symptom
initi
minim
progress
rapidli
becom
shortofbreath
shortli
return
southern
california
present
emerg
depart
reevalu
ed
repeat
chest
xray
fig
demonstr
subtl
patchi
opac
lung
new
prior
xray
day
ago
ct
fig
chest
reveal
multifoc
bilater
patchi
ground
glass
opac
predominantli
peripher
distribut
concern
atyp
pneumonia
possibl
viral
infect
test
perform
result
expect
h
later
along
standard
chemistri
hematolog
lab
reveal
abnorm
except
elev
procalcitonin
level
evalu
caus
atyp
pneumonia
simultan
sent
without
addit
find
thu
far
admit
hospit
dropletey
precaut
initi
note
temperatur
otherwis
normal
vital
sign
initi
antimicrobi
therapi
ceftriaxon
azithromycin
next
h
febril
respiratori
statu
rapidli
deterior
repeat
chest
xray
demonstr
evolut
bilater
multifoc
opac
consist
atyp
pneumonia
concern
superimpos
pulmonari
edema
underw
dialysi
even
hospit
day
toler
treatment
poorli
develop
new
atrial
fibril
rapid
ventricular
rate
despit
minim
ultrafiltr
respiratori
condit
continu
rapidli
declin
night
intub
transfer
intens
care
unit
icu
acut
hypox
respiratori
failur
shock
pulmonari
condit
continu
deterior
acut
respiratori
distress
syndrom
ard
requir
continu
mechan
ventil
high
peep
cm
well
pressor
support
effort
maintain
close
control
volum
statu
metabol
paramet
initi
continu
venoven
hemodiafiltr
set
esrd
deem
candid
remdesivir
compassion
use
trial
start
hydroxychloroquin
hospit
day
start
tocilizumab
given
continu
hemodynam
instabl
elev
inflammatori
marker
includ
interleukin
il
inabl
rule
superimpos
infect
also
broadspectrum
antibiot
coverag
vancomycin
piperacillintazobactom
sinc
hospit
day
clinic
cours
follow
close
multispecialist
team
depend
trajectori
may
requir
paralysi
well
aggress
pulmonari
hemodynam
support
prone
extracorpor
membran
oxygen
current
time
vasopressor
requir
remain
variabl
ratio
remain
critic
condit
past
day
tabl
summar
timelin
figur
show
chest
xray
ct
scan
demonstr
interstiti
pneumon
due
covid
infect
rapidli
develop
field
expect
infect
dialysi
patient
case
report
analys
recent
research
letter
arentz
et
al
clinic
characterist
patient
includ
longterm
dialysi
admit
icu
washington
state
describ
uniqu
featur
report
case
potenti
long
incub
period
assum
patient
contract
infect
south
korea
earli
januari
week
prior
first
present
certain
altern
could
one
first
commun
spread
case
identifi
southern
california
delay
diagnosi
first
day
like
recogn
treat
center
gastrointestin
manifest
may
part
infect
report
dialysisdepend
patient
notabl
healthier
younger
averag
dialysi
patient
unit
state
without
diabet
histori
hypertens
cardiac
diseas
yet
develop
ard
requir
ventilatori
support
case
report
highlight
import
consid
infect
varieti
clinic
present
may
initi
includ
typic
respiratori
symptom
prevent
ongo
exposur
potenti
affect
individu
gener
popul
also
highlight
need
rapidli
avail
test
patient
present
healthcar
set
even
nonsever
atyp
symptom
patient
commun
spread
diseas
travel
southern
california
utah
day
use
public
airport
commerci
flight
public
transport
potenti
exposur
could
avoid
test
suppli
public
health
recommend
would
differ
consequ
exposur
remain
unclear
unit
state
sinc
rapidli
increas
number
case
gastrointestin
present
patient
somewhat
unusu
delay
initi
diagnost
workup
day
notabl
howev
first
case
infect
confirm
unit
state
report
histori
nausea
vomit
admiss
follow
loos
stool
hospit
day
viral
nucleic
acid
loos
stool
respiratori
specimen
report
posit
recent
report
hubei
china
patient
studi
author
report
digest
symptom
uncommon
patient
patient
present
gastrointestin
symptom
longer
time
onset
admiss
evid
longer
coagul
higher
liver
enzym
level
henc
clinician
includ
nephrologist
recogn
digest
symptom
diarrhea
may
among
present
featur
infect
index
suspicion
may
need
rais
earlier
atrisk
patient
present
digest
symptom
challeng
exist
health
system
due
novelti
rapid
spread
asymptomat
shed
variabl
manifest
poor
outcom
multimorbid
elderli
person
mortal
rate
current
estim
time
lethal
influenza
though
incid
diseas
rise
may
chang
pandem
result
massiv
effort
worldwid
quarantin
suspect
individu
isol
affect
patient
unparallel
modern
histori
plan
flatten
curv
presum
way
health
system
expect
cope
crisi
reduc
demand
hospit
icu
bed
reason
higher
incid
mortal
infect
individu
sever
comorbid
includ
cardiovascular
diseas
still
unknown
prior
studi
suggest
angiotensinconvert
enzym
bind
capac
strongli
associ
coronaviru
infect
diseas
sever
may
differenti
upregul
acei
arb
aldosteron
antagonist
postul
express
may
increas
use
acei
arb
aldosteron
antagonist
particularli
diabet
patient
therefor
suggest
increas
express
may
facilit
infect
import
note
howev
higher
level
shown
protect
effect
acut
lung
injuri
reduc
progress
lung
injuri
ard
anim
studi
result
ongo
investig
potenti
new
therapi
inflammatori
lung
diseas
note
decreas
age
consist
demonstr
higher
mortal
morbid
older
popul
figur
show
pathophysiolog
interplay
viral
entri
lung
physiolog
center
around
current
treatment
increasingli
center
around
agent
includ
chloroquinebas
agent
like
hydroxychloroquin
antimalari
agent
shown
potent
antivir
activ
vitro
especi
hydroxychloroquin
lopinavirritonavir
also
use
clinic
howev
wherea
emerg
agent
infect
remdesivir
unfortun
patient
esrd
exclud
current
trial
toculizumab
antagonist
receptor
agent
use
treat
cytokinereleas
syndrom
sever
anticip
toxic
cartcel
therapi
differ
malign
similarli
sever
infect
hyperinflamm
immunosuppress
may
improv
surviv
preliminari
report
china
regard
patient
elev
level
pneumonia
given
clinic
deterior
patient
concern
hyperinflamm
elev
level
start
tocliziumab
work
treatment
sever
ill
patient
pandem
requir
continu
requir
broad
attent
public
health
offici
implement
social
distanc
mitig
rapid
spread
highli
contagi
potenti
lifethreaten
novel
viru
vaccin
develop
anticip
may
take
time
success
help
establish
herd
immun
protect
noninfect
popul
larg
scientif
medic
commun
face
unknown
surg
vulner
popul
alreadi
gather
routin
treatment
limit
space
exampl
infus
center
dialysi
center
place
great
risk
exposur
import
rapid
use
clinic
public
data
paramount
make
progress
spread
innov
report
one
first
patient
esrd
undergo
hemodialysi
infect
scenario
present
variou
epidemiolog
challeng
far
contain
infecti
spread
dialysi
unit
scenario
also
suggest
home
dialysi
mayb
protect
intervent
face
rapidli
infecti
pandem
research
work
contain
human
subject
research
materi
author
conflict
interest
disclos
kkz
support
nation
institut
healthnat
institut
diabet
digest
kidney
diseas
grant
well
philanthropist
grant
mr
harold
simmon
mr
loui
chang
dr
joseph
lee
aveo
cmr
support
research
grant
nation
institut
healthnat
institut
diabet
digest
kidney
diseas
philanthropist
grant
dr
joseph
lee
written
consent
public
obtain
immedi
famili
member
patient
applic
data
work
sponsor
